Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine

Aug 22, 2024•over 1 year ago

Contract Type

agreement

New Yorkpharmaceuticals

Description

Pfizer Inc. and BioNTech SE have received U.S. FDA approval for their Omicron KP.2-adapted COVID-19 vaccine, which will be available for individuals 12 years of age and older. Additionally, emergency use authorization has been granted for individuals 6 months through 11 years of age.

Company Information

Company

Pfizer

Location

66 Hudson Blvd E

New York, New York, United States

About

Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. Seagen is recognized for its advancements in cancer care and plays a significant role in the oncology market. Its dedication to research and development underpins its success in the competitive biotech landscape.

Related People

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months